Global X Management Company’s ResMed RMD Stock Holding History

Global X Management Company’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$722K	Buy	6,974 +405	+6%	+$41K	0.01%	584
2018 Q1	$647K	Buy	6,569 +163	+3%	+$15.4K	0.01%	563
2017 Q4	$543K	Buy	6,406 +1,107	+21%	+$91.5K	0.01%	527
2017 Q3	$408K	Buy	5,299 +572	+12%	+$43.8K	0.01%	590
2017 Q2	$368K	Buy	4,727 +423	+10%	+$30.3K	0.01%	594
2017 Q1	$310K	Buy	4,304 +1,177	+38%	+$81.3K	0.01%	607
2016 Q4	$194K	Buy	3,127 +734	+31%	+$45K	0.01%	656
2016 Q3	$155K	Buy	2,393 +1,017	+74%	+$67.7K	0.01%	643
2016 Q2	$87K	Buy	1,376 +832	+153%	+$49K	﹤0.01%	566
2016 Q1	$31K	Buy	544 +491	+926%	+$27.8K	﹤0.01%	677
2015 Q4	$3K	Buy	53 +12	+29%	+$676	﹤0.01%	760
2015 Q3	$2K	Buy	41 +12	+41%	+$646	﹤0.01%	912
2015 Q2	$2K	Buy	+29	New	+$1.83K	﹤0.01%	883

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Global X Management Company's RMD Position: Q2 2018 in Review

Global X Management Company increased its ResMed (RMD) stake by 6.2% in Q2 2018, buying an estimated $41K and bringing the position to 6,974 shares worth $722K. The position accounts for 0.01% of the portfolio, ranked #584.

Global X Management Company first reported a position in RMD in Q2 2015 and has held it in 13 quarters since. 465 funds tracked by Wall St. Rank hold RMD as of Q2 2018.

Global X Management Company held 6,974 shares of ResMed worth $722K as of Q2 2018.
Global X Management Company bought 405 ResMed shares in Q2 2018, an estimated $41K.
ResMed made up 0.01% of Global X Management Company's portfolio in Q2 2018, its #584 holding.
Global X Management Company first reported a position in ResMed in Q2 2015 and has held it in 13 quarters since.
465 funds tracked by Wall St. Rank held ResMed as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.